The increasing prevalence of chronic kidney disease and the growing number of patients requiring kidney replacement therapy represent a significant medical and economic challenge. The research group focuses on understanding the intricate relationships between metabolic disorders and kidney disease, as well as their role in the development of cardiovascular disease. It also examines the impact of common viral infections on kidney function.
Our work aims to investigate the causes of age-related decline in glomerular filtration rate (GFR), improve the precision of GFR estimation methods, and contribute to large clinical trials to identify optimal treatment strategies for patients with established kidney disease. Additionally, we seek to identify potential targets for future direct-acting antiviral therapies against BK Polyomavirus (BKPyV).
We adopt a multidisciplinary approach, incorporating epidemiological research, clinical studies, and experimental investigations to address these pressing issues in kidney and cardiovascular health.




















2025:
Iohexol clearance, but not estimated GFR, reveals a steeper GFR decline in patients with prediabetes. Kidney Int. 2025 Jul 9:S0085-2538(25)00519-8. doi: 10.1016/j.kint.2025.06.019. Online ahead of print.PMID: 40645290
NorKiBB: Norwegian Kidney Biopsy Biobank
P.I. Stein I Hallan, Norwegian University of Science and Technology, Trondheim, Norway
Grants from the Norwegian Research Council
Collaborator from our group: Marit Dahl Solbu
Nordic JIA study - 28 years’ follow-up substudy:
P.I. Ellen Nordal, UiT; NoSPeR Study Group
Grants from several sources
Collaborator from our group: Marit Dahl Solbu
2026 (ongoing):
2024:
2021:
2019: